TPX2 siRNA regulates growth and invasion of esophageal cancer cells

Biomedicine and Pharmacotherapy

Volumn 68, Issue 7, 2014, Pages 833-839

  Liu, Hong Chun ^a   Zhang, Gen Hao ^a   Liu, Yu Han ^b   Wang, Pan ^a   Ma, Jun Fen ^a   Su, Li Sha ^a   Li, Sheng Lei ^a   Zhang, Lan ^a   Liu, Jun Wen ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b ZHENGZHOU PEOPLE S HOSPITAL   (China)

Author keywords

Cell apoptosis cell cycle; Cell growth; Cell invasion ability; EC9706 cell line; TPX2 siRNA

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN; SMALL INTERFERING RNA; TARGETING PROTEIN FOR XENOPUS KINESIN LIKE PROTEIN 2; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; MESSENGER RNA; NUCLEAR PROTEIN; TPX2 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL COUNT; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGUS CANCER; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; ANIMAL; CELL CYCLE; ESOPHAGUS TUMOR; GENETICS; NONOBESE DIABETIC MOUSE; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; PROCEDURES; RNA INTERFERENCE; SCID MOUSE; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; HUMANS; MICE; MICE, INBRED NOD; MICE, NUDE; MICE, SCID; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84909630861     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2014.08.008     Document Type: Article

References (33)

1. Trieseimann N., Armstrong S., Rauw J., et al. Ran modulates spindle assembly by regulating a subset of TPX2 and Kid activities including Aurora-A activation. J Cell Sci 2003, 116(pt23):4791-4798.
2. Vos J.W., Pieuchot L., Evrard J.L., et al. The plant TPX2 protein regulates prospindle assembly before nuclear envelope. Plant Cell 2008, 20(10):2783-2797.
3. Tonon G., Wong K.K., Maulik G., et al. High-resolution genomie pro-files of human lung cancer. Proc Natl Acad Sei USA 2005, 102(27):9625-9630.
4. Kufer T.A., Sillje H.H., Korner R., et al. Human TPX2 is required for targeting Aurora-A kinase to the spindle. J Cell Biol 2002, 158(4):617-623.
5. Gruss O.J., Wittmann M., Yokoyama H., et al. Chromosome-induced microtubule assembly mediated by TPX2 is required for spindle formation in Hela cells. Nat Cell Biol 2002, 4(11):871-879.
6. Kan T., Sato F., Ito T., Matsumura N., et al. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 2009, 136(5):1689-1700.
7. Anderson M.R., Harrison R., Atherfold P.A., et al. Met receptor signaling: a key effector in esophageal adenocarcinoma. Clin Cancer Res 2006, 12(20 Pt 1):5936-5943.
8. Shigeishi H., Ohta K., Hiraoka M., et al. Expression of TPX2 in salivary gland carcinomas. Oncol Rep 2009, 21(2):341-344.
9. Lin D.M., Ma Y., Xiao T., et al. TPX2 expression and its significance in squamous cell carcinoma of lung. Zhonghua Bing Li Xue Za Zhi 2006, 35(9):540-544.
10. Colak D., Nofal A., Albakheet A., Nirmal M., et al. Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women. PLoS One 2013, 8(5):e63204.
11. Liu H.C., Li Y.Y., Liu Y.H., et al. Expression of TPX2 mRNA and its correlation with clinical pathology in esophageal cancer. J Clin Exp Pathol 2010, 26(2):151-153.
12. Aguirre-Portolés C., Bird A.W., Hyman A., et al. TPX2 controls spindle integrity, genome stability, and tumor development. Cancer Res 2012, 72(6):1518-1520.
13. Liu H.C., Liu Y.H., Li S.L., et al. Expression of TPX2 and Aurora A in esophageal squamous carcinoma and their significance in clinical pathology. Cancer Res Prev Treat 2009, 36(11):932-935.
14. Hong-Chun Liu, Yi Zhang, Xiu-Lin Wang, et al. Upregulation of the TPX2 gene is associated with enhanced tumor malignance of esophageal squamous cell carcinoma. Biomed Pharmacother 2013, 67:751-755.
15. Heidebrecht H.J., Buck F., Steinmann J., et al. P100: a novel proliferation-associated nuclear protein specifically restricted to cell cycle phases S, G2, and M. Blood 1997, 90:226-233.
16. Zhang Y., Heidebrecht H., Rott A., Schlegelberger B., Parwaresch R. Assignment of human proliferation associated p100 gene (C20orf1) to human chromosome band 20q11.2 by in situ hybridization. Cytogenet Cell Genet 1999, 11:182-183.
17. Wittmann T., Boleti H., Antony C., Karsenti E., Vernos I. Localization of the kinesin-like protein Xklp2 to spindle poles requires a leucine zipper, a microtubule-associated protein, and dynein. J Cell Biol 1999, 11:673-685.
18. Tulu U.S., Fagerstrom C., Ferenz N.P., Wadsworth P. Molecular requirements for kinetochore-associated microtubule formation in mammalian cells. Curr Biol 2006, 11:536-541.
19. Ozlü N., Srayko M., Kinoshita K., Habermann B., O'toole E.T., Müller-Reichert T., et al. An essential function of the C. elegans ortholog of TPX2 is to localize activated aurora A kinase to mitotic spindles. Dev Cell 2005, 11:237-248.
20. Stewart S., Fang G. Anaphase-promoting complex/cyclosome controls the stability of TPX2 during mitotic exit. Mol Cell Biol 2005, 11:10516-10527.
21. Lee Pearl RNAi technology and its application in the treatment of diseases.[J]. J New Med 2008, 18(4):226-228.
22. Shibata M.A., Ambati J., Shibata E., et al. Mammary cancer gene therapy targeting lymphangiogenesis: VEGF-C siRNA and soluble VEGF receptor-2, a splicing variant. Med Mol Morphol 2012, 45(4):179-184.
23. Tang Z.Y., Liu Y., Liu L.X., et al. RNAi-mediated MMP-9 silencing inhibits mouse melanoma cell invasion and migration in vitro and in vivo. Cell Biol Int 2013, 37(8):849-854.
24. Yang Shi, Shuqun Hu, Qingwei Song, et al. Gene silencing of 4-1BB by RNA interference inhibits acute rejection in rats with liver transplantation. Biomed Res Int 2013, 2013:192738.
25. Li juan Zhang, He Huang, et al. TPX2 in malignantly transformed human bronchial epithelial cells by anti-benzo[a]pyrene-7,8-diol-9,10-epoxide [J]. Toxicology 2008, 252(1-3):49-55.
26. Sieber O., Heinimann K., Tomlinson I. Genomic stability and tumorigenesis. Semin Cancer Biol 2005, 11:61-66.
27. Warner S.L., Stephens B.J., Nwokenkwo S., et al. Validation of TPX2 as a potential therapeutic target in pancreatic cancer cells. Clin Cancer Res 2009, 15(21):6519-6528.
28. Furukawa T., Kanai N., Shiwaku H.O., et al. AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer [J]. Oncogene 2006, 25(35):4831-4839.
29. Shigeishi H., Fujimoto S., Hiraoka M., et al. Overexpression of the receptor for hyaluronan-mediated motility, correlates with expression of microtubule-associated protein in human oral squamous cell carcinomas. Int J Oncol 2009, 34(6):1565-1571.
30. Pascreau G., Eckerdt F., Lewellyn A.L., et al. Phosphorylation of p53 is regulated by TPX2-Aurora A in xenopus oocytes. Biol Chem 2009, 284(9):5497-5505.
31. Scharer C.D., Laycock N., Osunkoya A.O., et al. Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells. J Transl Med 2008, 11(6):79.
32. Aguirre-Portolés C., Bird A.W., Hyman A., et al. Tpx2 controls spindle integrity, genome stability, and tumor development. Cancer Res 2012, 72(6):1518-1528.
33. Vainio P., Mpindi J.P., Kohonen P., et al. High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer. PLoS One 2012, 7(6):e39801.